EAU 2014 - Poster: OnabotulinumtoxinA reduces urinary incontinence and improves quality of life in overactive bladder patients regardless of use of clean intermittent catheterisation or the presence of urinary tract infection

STOCKHOLM, SWEDEN (UroToday.com) - Presented by Karel Everaert,1 Jennifer Gruenenfelder,2 Heinrich Schulte-Baukloh,3 Steven Guard,4 Yan Zheng,5 David Sussman6 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.

Poster-583 EAU thumb

1Ghent University Hospital, Gent, Belgium; 2Orange County Urology Associates, Laguna Hills, CA, USA; 3St. Hedwig-Krankenhaus, Berlin, Germany; 4Allergan, Ltd., Marlow, UK; 5Allergan, Inc., Bridgewater, NJ, USA; 6Rowan University School of Osteopathic Medicine, Stratford, NJ, USA

 

email news signup